Title: Clinic effect study of treatment on T2-DM utilizing rosiglitazone associated with insulin
Abstract: Objective To discover clinic effect on T2-DM utilizing rosiglitazone associated with insulin. Methods 42 T2-DM patients were divided into two groups:Ins group,n=21;Ins+Ros group,n=21. In Ins group,Novolin R was hypodemic injected before three meals and Novolin N before retiring;In Ins+Ros group,rosiglitazone was added with 4mg/d,justified from 4-8mg/d. Time of therapy was 16 weeks. Index of BMI,FPG,2hPG were measured pro-therapy and post-therapy. Results In Ins+Ros group,index of FPG,2hPG,HbA1c,TG,TC,LDL-C descended obviously compared with pro-therapy and Ins group post-therapy(P0.05),Index of BMI,FCP changed slightly(P0.05). Conclusions Rosiglitazone can heal insulin resistance obviously and lower blood sugar,blood fat,and it can improve T2-DM patients treatment.
Publication Year: 2009
Publication Date: 2009-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot